-
Something wrong with this record ?
Positive effects of antihypertensive treatment on aortic stiffness in the general population
J. Seidlerová, J. Filipovský, O. Mayer, P. Wohlfahrt, R. Cífková,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24048486
DOI
10.1038/hr.2013.113
Knihovny.cz E-resources
- MeSH
- Pulse Wave Analysis MeSH
- Antihypertensive Agents therapeutic use MeSH
- Aorta drug effects physiology MeSH
- Adult MeSH
- Hypertension drug therapy pathology physiopathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Aging physiology MeSH
- Models, Statistical MeSH
- Vascular Stiffness drug effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Aortic stiffness is strongly related to age and mean arterial pressure (MAP). In the present analysis, we investigated whether antihypertensive treatment modulates the association of the aortic pulse wave velocity (PWV) with age and with MAP in the general population. In the Czech post-MONICA cross-sectional study, we measured the PWV in 735 subjects (mean age 61.2±7.8 years, 54.1% women, 44.3% on antihypertensive medication). We used a linear regression model to assess the effect of treatment on the PWV. The independent covariates in our analysis included sex, age, MAP, heart rate, body mass index, plasma glucose, low-density lipoprotein cholesterol, smoking and observer. The patients receiving treatment were older (64.1±6.7 vs. 58.9±7.8 years), had higher systolic blood pressure (135.9±16.2 vs. 130.1±16.5 mm Hg) and had higher pulse wave velocity (9.1±2.2 vs. 8.2±2.1 m s(-1); P for all <0.0001) than untreated subjects. After adjustment for MAP, the use of treatment modified the association between age and the PWV (regression equations, treated patients 9.68-0.009 × age vs. untreated subjects 6.98+0.020 × age, difference of regression slopes, F=11.2; P=0.0009). In analyses adjusted for age, treatment was associated with a smaller increase of the PWV with MAP (treated patients 9.63-0.006 × MAP vs. untreated subjects 7.18+0.010 × MAP, F=10.70; P=0.0001). These results were driven primarily by subjects whose blood pressure was below 140/90 mm Hg. In the cross-sectional analysis from a random sample of the general population, antihypertensive treatment was associated with a less steep increase in the PWV with age and the mean arterial pressure. Further longitudinal studies are needed to confirm this finding.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074650
- 003
- CZ-PrNML
- 005
- 20141008122704.0
- 007
- ta
- 008
- 141006s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/hr.2013.113 $2 doi
- 035 __
- $a (PubMed)24048486
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Seidlerová, Jitka $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
- 245 10
- $a Positive effects of antihypertensive treatment on aortic stiffness in the general population / $c J. Seidlerová, J. Filipovský, O. Mayer, P. Wohlfahrt, R. Cífková,
- 520 9_
- $a Aortic stiffness is strongly related to age and mean arterial pressure (MAP). In the present analysis, we investigated whether antihypertensive treatment modulates the association of the aortic pulse wave velocity (PWV) with age and with MAP in the general population. In the Czech post-MONICA cross-sectional study, we measured the PWV in 735 subjects (mean age 61.2±7.8 years, 54.1% women, 44.3% on antihypertensive medication). We used a linear regression model to assess the effect of treatment on the PWV. The independent covariates in our analysis included sex, age, MAP, heart rate, body mass index, plasma glucose, low-density lipoprotein cholesterol, smoking and observer. The patients receiving treatment were older (64.1±6.7 vs. 58.9±7.8 years), had higher systolic blood pressure (135.9±16.2 vs. 130.1±16.5 mm Hg) and had higher pulse wave velocity (9.1±2.2 vs. 8.2±2.1 m s(-1); P for all <0.0001) than untreated subjects. After adjustment for MAP, the use of treatment modified the association between age and the PWV (regression equations, treated patients 9.68-0.009 × age vs. untreated subjects 6.98+0.020 × age, difference of regression slopes, F=11.2; P=0.0009). In analyses adjusted for age, treatment was associated with a smaller increase of the PWV with MAP (treated patients 9.63-0.006 × MAP vs. untreated subjects 7.18+0.010 × MAP, F=10.70; P=0.0001). These results were driven primarily by subjects whose blood pressure was below 140/90 mm Hg. In the cross-sectional analysis from a random sample of the general population, antihypertensive treatment was associated with a less steep increase in the PWV with age and the mean arterial pressure. Further longitudinal studies are needed to confirm this finding.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a stárnutí $x fyziologie $7 D000375
- 650 _2
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a aorta $x účinky léků $x fyziologie $7 D001011
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x farmakoterapie $x patologie $x patofyziologie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a statistické modely $7 D015233
- 650 _2
- $a analýza pulzové vlny $7 D063177
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a tuhost cévní stěny $x účinky léků $7 D059289
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Filipovský, Jan $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
- 700 1_
- $a Mayer, Otto $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
- 700 1_
- $a Wohlfahrt, Peter $u 1] Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic [2] Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Cífková, Renata $u 1] Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic [2] Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00006041 $t Hypertension research : official journal of the Japanese Society of Hypertension $x 1348-4214 $g Roč. 37, č. 1 (2014), s. 64-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24048486 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141008123052 $b ABA008
- 999 __
- $a ok $b bmc $g 1042533 $s 873562
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 37 $c 1 $d 64-8 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
- LZP __
- $a Pubmed-20141006